Schechter Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$229K Sell
2,021
-159
-7% -$17K 0.02% 528
2024
Q4
$230K Sell
2,180
-83
-4% -$8.91K 0.02% 543
2024
Q3
$244K Sell
2,263
-83
-4% -$9.06K 0.02% 543
2024
Q2
$255K Sell
2,346
-1,403
-37% -$165K 0.02% 506
2024
Q1
$495K Sell
3,749
-94
-2% -$11.7K 0.04% 375
2023
Q4
$468K Sell
3,843
-398
-9% -$44.4K 0.04% 365
2023
Q3
$476K Buy
4,241
+752
+22% +$95.5K 0.05% 354
2023
Q2
$508K Buy
3,489
+35
+1% +$4.76K 0.05% 382
2023
Q1
$446K Buy
3,454
+81
+2% +$10.2K 0.04% 438
2022
Q4
$430K Sell
3,373
-71
-2% -$8.24K 0.04% 542
2022
Q3
$360K Buy
3,444
+182
+6% +$20K 0.04% 628
2022
Q2
$342K Buy
3,262
+85
+3% +$10.1K 0.03% 655
2022
Q1
$407K Sell
3,177
-380
-11% -$45.8K 0.04% 592
2021
Q4
$439K Buy
+3,557
New +$466K 0.04% 548

Other funds holding ZBH

Schechter Investment Advisors's ZBH Position: Q1 2025 in Review

Schechter Investment Advisors reduced its Zimmer Biomet (ZBH) stake by 7.3% in Q1 2025, selling an estimated $17K and leaving 2,021 shares worth $229K. The position accounts for 0.02% of the portfolio, ranked #528.

Schechter Investment Advisors first reported a position in ZBH in Q4 2021 and has held it in 14 quarters since. The position peaked at $508K in Q2 2023. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Schechter Investment Advisors held 2,021 shares of Zimmer Biomet worth $229K as of Q1 2025.
  • Schechter Investment Advisors sold 159 Zimmer Biomet shares in Q1 2025, an estimated $17K.
  • Zimmer Biomet made up 0.02% of Schechter Investment Advisors's portfolio in Q1 2025, its #528 holding.
  • Schechter Investment Advisors first reported a position in Zimmer Biomet in Q4 2021 and has held it in 14 quarters since.
  • Schechter Investment Advisors's Zimmer Biomet position peaked at $508K in Q2 2023.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Schechter Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.